THERAPEUTIC DOSES OF ERYTHROMYCIN ESTEOLATE IS NOT CHOLESTATIC IN RATS IN VIVOFIEBIGER I; ANWER MS; MEGNER D et al.1983; NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY; ISSN 0028-1298; DEU; DA. 1983; VOL. 322; NO 4; PP. 295-297; BIBL. 11 REF.Article

DIPHTHERIA CARRIERS AND THE EFFECT OF ERYTHROMYCINE THERAPYMILLER LW; BICKHAM S; JONES WL et al.1974; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1974; VOL. 6; NO 2; PP. 166-169; BIBL. 12REF.Article

PERFUSION OF THE ISOLATED RAT LIVER WITH ERYTHROMYCIN ESTOLATE AND OTHER DERIVATIVES = PERFUSION DU FOIE DE RAT ISOLE PAR L'ESTOLATE D'ERYTHROMYCINE ET D'AUTRES DERIVESKENDLER J; ANURAS S; LABORDA O et al.1972; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1972; VOL. 139; NO 4; PP. 1272-1275; BIBL. 16REF.Serial Issue

JAUNDICE DUE TO ERYTHROMYCIN ESTOLATELUNZER MR; HUANG SN; WARD KM et al.1975; GASTROENTEROLOGY; U.S.A.; DA. 1975; VOL. 68; NO 5 PART. 1; PP. 1284-1291; BIBL. 19REF.Article

ESTOLATE AND STEARATE FORMS OF ERYTHROMYCIN IN THE TREATMENT OF ACUTE BETA HAEMOLYTIC STREPTOCOCCAL PHARYNGITIS = LES FORMES ESTOLATE ET STEARATE DE L'ERYTHROMICINE DANS LE TRAITEMENT DES PHARYNGITES AIGUES A STREPTOCOQUE BETA HEMOLYTIQUERYAN DC; DREHER GH; HURST JA et al.1973; MED. J. AUSTRAL.; AUSTRAL.; DA. 1973; VOL. 1; NO 1; PP. 20-21; BIBL. 4 REF.Serial Issue

THE CONCENTRATION OF ANTIBIOTICS IN SINUS SECRETIONS: AMPICILLIN, CEPHRADINE AND ERYTHROMYCINESTOLATEAXELSSON A; BRORSON JE.1974; ANN. OTOL. RHINOL. LARYNGOL.; U.S.A.; DA. 1974; VOL. 83; NO 3; PP. 323-331; BIBL. 18REF.Article

ERYTHROMYCIN ESTOLATE AND JAUNDICEINMAN WHW; RAWSON NSB.1983; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1983; VOL. 286; NO 6382; PP. 1954-1955; BIBL. 3 REF.Article

PHARMACOKINETICS OF ERYTHROMYCIN ETHYLSUCCINATE AND ESTOLATE IN INFANTS UNDER 4 MONTHS OF AGEPATAMASUCON P; KAOJARERN S; KUSMIESZ H et al.1981; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1981; VOL. 19; NO 5; PP. 736-739; BIBL. 9 REF.Article

ERYTHROMYCIN ESTOLATE HEPATOTOXICITY: A CASE REPORT AND REVIEW OF THE LITERATURE.YOUNG B; BARTLE WR.1977; CANAD. PHARM. J.; CANADA; DA. 1977; VOL. 110; NO 12; PP. 9-11; BIBL. 16 REF.Article

LIVER CELL CULTURE TOXICITY AND SURFACTANT POTENCY OF ERYTHROMYCIN DERIVATIVES = LA TOXICITE AVEC LES CULTURES DE CELLULES HEPATIQUES ET LE POUVOIR SURFACTIF DES DERIVES DE L'ERYTHROMYCINEDUJOVNE CA.1975; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1975; VOL. 32; NO 1; PP. 11-20; BIBL. 10REF.Article

A SIMPLE THIN-LAYER CHROMATOGRAPHIC IDENTIFICATION PROCEDURE FOR ERYTHROMYCIN BASE, STEARATE, ESTOLATE AND ETHYLSUCCINATE.VILIM A; LEBELLE MJ; WILSON WL et al.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 133; NO 1; PP. 239-244; BIBL. 9 REF.Article

COMPARATIVE BIOAVAILABILITY EVALUATION OF ERYTHROMYCIN BASE AND ITS SALTS AND ESTERS. I: ERYTHROMYCIN ESTOLATE CAPSULES VERSUS ENTERIC-COATED ERYTHROMYCIN BASE TABLETSDISANTO AR; TSERNG KY; CHODOS DJ et al.1980; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1980; VOL. 20; NO 7; PP. 437-443; BIBL. 21 REF.Article

Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in ratXIAOYAN LU; YU TIAN; XUEPING LIAN et al.Food and chemical toxicology. 2014, Vol 65, pp 343-355, issn 0278-6915, 13 p.Article

TREATMENT OF ACUTE BACTERIOL INFECTIONS OF THE UPPER RESPIRATORY TRACT.NADKARNI MS; SHAH PA; THAKURDESAI S et al.1977; CURR. MED. RES. OPINION; G.B.; DA. 1977; VOL. 4; NO 8; PP. 544-554; BIBL. 24 REF.Article

Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxinGAETA, G. B; ADINOLFI, L. E; UTILI, R et al.Life sciences (1973). 1986, Vol 39, Num 5, pp 453-460, issn 0024-3205Article

THE BIOAVAILABILITY OF PEDIATRIC SUSPENSIONS OF TWO ERYTHROMYCIN ESTERSBECHTOL LD; DE SANTE KA; FOGLESONG MA et al.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 29; NO 1; PART. 1; PP. 52-59; BIBL. 9 REF.Article

THE TREATMENT OF BETA HEMOLYTIC STREPTOCOCCAL PHARYNGITIS. COMPARISON OF AMOXICILLIN, ERYTHROMYCIN ESTOLATE, AND PENICILLIN V.BREESE BB; DISNEY FA; GREEN JL et al.1977; CLIN. PEDIATR.; U.S.A.; DA. 1977; VOL. 16; NO 5; PP. 460-463; BIBL. 3 REF.Article

Analysis of erythromycin estolate by liquid chromatographyCACHET, T; DELRUE, M; PAESEN, J et al.Journal of pharmaceutical and biomedical analysis. 1992, Vol 10, Num 10-12, pp 851-860, issn 0731-7085Conference Paper

CONCENTRATIONS OF ERYTHROMYCIN IN SERUM AND TONSIL: COMPARISON OF THE ESTOLATE AND ETHYL SUCCINATE SUSPENSIONS.GINSBURG CM; MCCRACKEN GH JR; CULBERTSON MC JR et al.1976; J. PEDIATR.; U.S.A.; DA. 1976; VOL. 89; NO 6; PP. 1011-1013; BIBL. 12 REF.Article

COMPLETE BILIARY OBSTRUCTION DUE TO ERYTHROMYCIN ESTOLATE ADMINISTRATION IN AN INFANTKROWCHUK D; SEASHORE JH.1979; PEDIATRICS; USA; DA. 1979; VOL. 64; NO 6; PP. 956-958; BIBL. 5 REF.Article

ERYTHROMYCIN ESTERS. COMPARATIVE IN-VIVO HYDROLYSIS AND BIOAVAILABILITY.BECHTOL LD; STEPHENS VC; PUGH CT et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 4 PART. 2; PP. 610-622; BIBL. 4 REF.Article

PROBLEMS OF BIOAVAILABILITY OF ERYTHROMYCINS.EASTERBROOK SM; HERSEY JA.1976; AUSTRAL. J. PHARM. SCI.; AUSTRAL.; DA. 1976; VOL. 5; NO 4; PP. 103-106; BIBL. 24 REF.Article

SELECTION OF AN ORAL ERYTHROMYCIN PRODUCTFRASER DG.1980; AMER. J. HOSP. PHARM.; USA; DA. 1980; VOL. 37; NO 9; PP. 1199-1205; BIBL. 35 REF.Article

ERYTHROMYCIN JAUNDICE: DIAGNOSIS BY AN IN VITRO CHALLENGE TEST.COOKSLEY WGE; POWELL LW.1977; AUSTRAL. NEW ZEAL. J. MED.; AUSTRAL.; DA. 1977; VOL. 7; NO 3; PP. 291-293; BIBL. 17 REF.Article

PLASMA LEVELS AND RELATIVE SYSTEMIC AVAILABILITY OF ERYTHROMYCIN ESTOLATE CAPSULE AND LIQUIDE SUSPENSION FORMULATIONS IN MAN.DUGAL R; COOPER SF; BERTRAND M et al.1976; CANAD. J. PHARM. SCI.; CANADA; DA. 1976; VOL. 11; NO 3; PP. 92-95; BIBL. 13 REF.Article